Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Surgery. 2019 Sep 9;167(1):10–17. doi: 10.1016/j.surg.2019.03.031

Table 3.

Details and outcomes of patients with regional recurrence

Patient Multifocality status Histological details Time to recurrence (years) Level of recurrence Management of recurrence Final Outcome - ATA* response to treatment
1 MFD Classical Variant, 1.3 cm, no VI§, mETE, negative margins 1.2 Ipsilateral Level 3 CT + MRND# NED†† - Excellent
2 UFD Classical Variant, 1.4 cm, focal VI, no ETE, negative margins 6.0 Ipsilateral Level 2 CT + MRND NED – Indeterminate
3 MFD Classical Variant, 0.8 cm, no VI, no ETE, positive margins 10.6 Contralateral Level 2,4 CT + MRND NED – Excellent
4 MFD Follicular Variant, 1.8 cm, no VI, no ETE, positive margins 11.3 Contralateral Level 6 CT + TEGD** NED - Indeterminate
5 UFD Classical Variant, 1.7 cm, no VI, no ETE, negative margins 15.3 Ipsilateral Level 4 CT + MRND NED - Unknown
*

ATA – American Thyroid Association

MFD – multifocal disease

UFD – unifocal disease

§

VI – vascular invasion

mETE – microscopic extrathyroidal extension

CT – completion thyroidectomy

#

MRND – modified radical neck dissection

**

TEGD – tracheoesophageal groove dissection

††

NED – no evidence of disease